Article Text

other Versions

PDF
Morbidity and mortality in preterm neonates with patent ductus arteriosus on day 3
  1. Anna Sellmer1,2,3,
  2. Jesper Vandborg Bjerre2,
  3. Michael Rahbek Schmidt4,
  4. Patrick J McNamara5,
  5. Vibeke Elisabeth Hjortdal6,
  6. Bente Høst2,
  7. Bodil Hammer Bech7,
  8. Tine Brink Henriksen2,3
  1. 1Department of Pediatrics, Herning Regional Hospital, Herning, Denmark
  2. 2Department of Pediatrics, Aarhus University Hospital, Aarhus, Denmark
  3. 3Perinatal Epidemiology Research Unit, Aarhus University, Aarhus, Denmark
  4. 4Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
  5. 5Department of Neonatology, Hospital for Sick Children, Toronto, Canada
  6. 6Department of Cardiothoracic Surgery, Aarhus University Hospital, Aarhus, Denmark
  7. 7Department of Public Health, Section for Epidemiology, Aarhus University, Aarhus, Denmark
  1. Correspondence to Anna Sellmer, Department of Pediatrics, Herning Regional Hospital, Gl Landevej 61, 7400 Herning, Denmark; anna.sellmer{at}ki.au.dk

Abstract

Objective To assess the association between a patent ductus arteriosus (PDA) on day 3 of life and severe morbidity and mortality.

Design Cohort study.

Setting Neonatal Intensive Care Unit, Aarhus University Hospital, Denmark.

Patients All neonates with a gestational age less than 32 weeks admitted from 2010 to 2012.

Interventions All neonates (n=183) were routinely screened with echocardiography for PDA on day 3 of life. Information on baseline characteristics and outcome was collected by structured coding sheets and medical records.

Main outcome measures The association among PDA diameter and pulmonary haemorrhage, intraventricular haemorrhage (IVH), necrotising enterocolitis, bronchopulmonary dysplasia (BPD), death, and the composite outcome of death or severe morbidity was assessed.

Results In neonates, born prior to 28 gestational weeks, a PDA on day 3 of life was associated with a threefold increase in odds of death or severe morbidity compared with neonates without PDA (OR=3.4; CI 1.1 to 11). The odds were highest in neonates with a large PDA (diameter ≥1.5 mm). Neonates with a large PDA were also found to have increased odds of IVH (OR 4.2; CI 1.3 to 14) and BPD (OR 3.7; CI 1.0 to 14) compared with neonates with no PDA.

Conclusions In neonates born with a gestational age below 28 weeks the presence of a PDA on day 3 of life was associated with adverse outcome; this association was even more pronounced with a large PDA. Thus, early echocardiography may facilitate the identification of neonates suitable for a targeted approach to intervention in future randomised controlled trials.

  • Neonatology
  • Epidemiology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.